[News] CAR T-cells for relapsed B-cell ALL in adults

Adults with relapsed B-cell acute lymphoblastic leukaemia (ALL) might achieve durable responses to chimeric antigen receptor (CAR) T-cell therapy, according to recent findings.

Source: The Lancet Oncology - February 8, 2018 Category: Cancer & Oncology Authors: Judith A Gilbert Tags: News Source Type: research